VI
PBH icon

Versor Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Versor Investments’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,083
Closed -$725K – 853
2025
Q2 		$725K Buy
9,083
+783
+9% +$65.5K 0.13% 262
2025
Q1 		$714K Buy
+8,300
New +$681K 0.12% 301
2021
Q4 		– Sell
-7,004
Closed -$393K – 627
2021
Q3 		$393K Buy
+7,004
New +$385K 0.01% 316

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Versor Investments's PBH Position: Q3 2025 in Review

Versor Investments sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 9,083 shares — an estimated $725K sold.

Versor Investments first reported a position in PBH in Q3 2021 and held it in 3 quarters. The position peaked at $725K in Q2 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Versor Investments reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 9,083 Prestige Consumer Healthcare shares in Q3 2025, an estimated $725K.
  • Versor Investments first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 3 quarters.
  • Versor Investments's Prestige Consumer Healthcare position peaked at $725K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.